SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-008029
Filing Date
2017-08-03
Accepted
2017-08-03 16:41:14
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 AERI 6.30.2017 10-Q aerie63017.htm 10-Q 755138
2 AERI 6.30.2017 EX 31.1 aeri6302017ex311.htm EX-31.1 16405
3 AERI 6.30.2017 EX 31.2 aeri6302017ex312.htm EX-31.2 16508
4 AERI 6.30.2017 EX 32.1 aeri6302017ex321.htm EX-32.1 10029
5 AERI 6.30.2017 EX 32.2 aeri6302017ex322.htm EX-32.2 9977
  Complete submission text file 0001628280-17-008029.txt   4078698

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aeri-20170630.xml EX-101.INS 833866
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20170630.xsd EX-101.SCH 32008
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20170630_cal.xml EX-101.CAL 50536
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20170630_def.xml EX-101.DEF 117337
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20170630_lab.xml EX-101.LAB 427354
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20170630_pre.xml EX-101.PRE 237510
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 171005641
SIC: 2836 Biological Products, (No Diagnostic Substances)